AstraZeneca’s Lung Cancer Drug Hits Milestone: The London Rush
Operators work on the cartoner and casepacker machine at AstraZeneca Plc's new Biologics factory in Sodertalje, Sweden.
Photographer: Mikael Sjoberg/BloombergThis article is for subscribers only.
This morning’s drip feed of corporate news reflects the lull before the earnings season soon to descend. Among the few updates, management changes are ahead for online trading platform IG Group, whose CEO will be taking a short medical leave, while AstraZeneca unveiled “compelling evidence” on the potential of its lung cancer drug developed in partnership with Tokyo-based Daiichi Sankyo. Meanwhile, in Westminster, Prime Minister Rishi Sunak is preparing for a state visit from US President Joe Biden.
Here’s the key business news from London this morning: